CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women
Open Access
- 16 February 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 13 (4), 231-236
- https://doi.org/10.1093/molehr/gam004
Abstract
The CYP17 gene is involved in steroid hormone metabolism and has been proposed as a low penetrance gene for breast cancer. We aimed to investigate the associations between the CYP17 genotype and breast cancer risk factors, such as age at menarche, menstrual cycle length, oral contraceptive (OC) use, and BRCA mutation status among 258 healthy young women, aged ≤40, from 158 breast cancer high-risk families. Questionnaires including questions on reproductive factors and OC use were completed and blood samples were obtained from all women. CYP17 (rs743572) was genotyped with sequencing in 254 women. The main findings were that short menstrual cycles (Ptrend = 0.002, adjusted for family clustering). Each A2 allele was associated with a 7 months earlier OC start (17.8, 17.0, and 16.6 years; Ptrend = 0.014, adjusted for age at menarche, ever-smoking and family clustering). Homozygosity for the A2 allele was more common among known non-carriers from BRCA1/2 families compared with other high-risk women OR 2.92 (95% CI 1.49–5.73; P = 0.002, adjusted for family clustering). We found no association between CYP17 genotype and age at menarche. In conclusion, this study suggests that short menstrual cycles, age at first OC use and BRCA mutation status may need to be considered in studies exploring the relationships between CYP17 and risk factors for early onset breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testingEuropean Journal of Cancer, 2005
- Menstrual Cycle Characteristics and Incidence of Premenopausal Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- Cyp17, Urinary Sex Steroid Levels and Breast Cancer Risk in Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- BRCA1 and BRCA2: 1994 and beyondNature Reviews Cancer, 2004
- Regressive logistic and proportional hazards disease models for within‐family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancerGenetic Epidemiology, 2003
- Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre‐menopausal womenInternational Journal of Cancer, 2002
- ABC of breast diseases: Breast cancer---epidemiology, risk factors, and geneticsBMJ, 2000
- Hormonal carcinogenesisCarcinogenesis: Integrative Cancer Research, 2000
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological ageBJOG: An International Journal of Obstetrics and Gynaecology, 1984